Antibacterial and antifungal activity of lawsone and novel naphthoquinone derivatives

被引:89
作者
Rahmoun, N. M. [1 ]
Boucherit-Otmani, Z. [1 ]
Boucherit, K. [1 ]
Benabdallah, M. [2 ]
Villemin, D. [3 ]
Choukchou-Braham, N. [2 ]
机构
[1] Tlemcen Univ, Fac Sci, Dept Biol, Lab Antibiot Antifong Phys Chim Synth & Activ Bio, Tilimsen 13000, Algeria
[2] Tlemcen Univ, Fac Sci, Dept Chem, Lab Catalyse & Synth Chim Organ, Tilimsen 13000, Algeria
[3] Univ Caen, CNRS, LCMT UMR 6507, ENS1CAEN,UCBN, F-14050 Caen, France
来源
MEDECINE ET MALADIES INFECTIEUSES | 2012年 / 42卷 / 06期
关键词
Naphthoquinone; Lawsone; Candida albicans; INFECTIOUS-DISEASES-SOCIETY; BAD BUGS; 2-HYDROXY-1,4-NAPHTHOQUINONE; ANTIBIOTICS; ANALOGS; DRUGS;
D O I
10.1016/j.medmal.2012.05.002
中图分类号
R51 [传染病];
学科分类号
100201 [内科学];
摘要
Introduction. - Naphthoquinone derivatives are under investigation as potential therapeutic agents. The antibacterial and antifungal activity of lawsone and of some novel naphthoquinone derivatives was assessed in vitro. Methods. - The antimicrobial activity was determined using diffusion disk and the broth microdilution methods against seven bacteria and three Candida species, according to recommendations of the Clinical and Laboratory Standards Institute. Results. - Two compounds (P05 et P06) presented a good antibacterial effectiveness against two gram-positive bacteria. No antifungal potency was observed against the three Candida albicans strains used in the test. Conclusion. - Our results prove that the introduction of substituents on ketone function position 4 decreased the antimicrobial properties of the synthetized compounds. (C) 2012 Published by Elsevier Masson SAS.
引用
收藏
页码:270 / 275
页数:6
相关论文
共 38 条
[1]
[Anonymous], 2005, NATURAL PRODUCTS DRU
[2]
BAUCH HJ, 1980, Z NATURFORSCH C, V35, P936
[3]
Antibacterial effect of 2-hydroxy-N-(3,4-dimethyl-5-isoxazolyl)-1,4-naphthoquinone-4-imine on Staphylococcus aureus [J].
Bogdanov, P ;
Albesa, I ;
Sperandeo, NR ;
Luna, C ;
deBertorello, MM .
EXPERIENTIA, 1996, 52 (06) :600-604
[4]
TETRACYCLINES, MOLECULAR AND CLINICAL ASPECTS [J].
CHOPRA, I ;
HAWKEY, PM ;
HINTON, M .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1992, 29 (03) :245-277
[5]
Exploiting current understanding of antibiotic action for discovery of new drugs [J].
Chopra, I ;
Hesse, L ;
O'Neill, AJ .
JOURNAL OF APPLIED MICROBIOLOGY, 2002, 92 :4S-15S
[6]
Treatment of health-care-associated infections caused by Gram-negative bacteria: a consensus statement [J].
Chopra, Ian ;
Schofield, Christopher ;
Everett, Martin ;
O'Neill, Alex ;
Miller, Keith ;
Wilcox, Mark ;
Frere, Jean-Marie ;
Dawson, Mike ;
Czapiewski, Lloyd ;
Urleb, Uros ;
Courvalin, Patrice .
LANCET INFECTIOUS DISEASES, 2008, 8 (02) :133-139
[7]
CLSI, 2008, REF METH BROTH DIL A, V28
[8]
AN OVERVIEW OF NOSOCOMIAL INFECTIONS, INCLUDING THE ROLE OF THE MICROBIOLOGY LABORATORY [J].
EMORI, TG ;
GAYNES, RP .
CLINICAL MICROBIOLOGY REVIEWS, 1993, 6 (04) :428-442
[9]
Espinel-Ingroff A., 2007, CLIN MICROBIOL NEWSL, V29, P97, DOI DOI 10.1016/j.clinmicnews.2007.06.001
[10]
FLOREANI M, 1992, J PHARMACOL EXP THER, V260, P468